Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease in the world, with a global prevalence of 25%. MASLD has an estimated prevalence of 34% in the United ...
Patients with type 2 diabetes mellitus (T2DM) have a significantly higher risk of cardiovascular disease (CVD) compared to the general population. Accurately predicting this risk is crucial for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results